Scinai Immunotherapeutics (SCNI) Total Debt Growth (1y) (2019 - 2025)
Scinai Immunotherapeutics (SCNI) Total Debt Growth (1y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 103.99% |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 3.84% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.07% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Scinai Immunotherapeutics | 352,860.00 | -3.11 Bn | -1.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -8.92% |
| Jun 30, 2025 | -96.09% |
| Dec 31, 2024 | -96.54% |
| Sep 30, 2024 | -96.61% |
| Jun 30, 2024 | -14.79% |
| Mar 31, 2024 | -8.94% |
| Dec 31, 2023 | -3.42% |
| Sep 30, 2023 | 12.06% |
| Jun 30, 2023 | 44.21% |
| Mar 31, 2023 | -1.94% |
| Dec 31, 2022 | -25.69% |
| Sep 30, 2022 | -22.29% |
| Jun 30, 2022 | -99.98% |
| Mar 31, 2022 | -99.97% |
| Dec 31, 2021 | -99.96% |
| Sep 30, 2021 | 14.51% |
| Jun 30, 2021 | -45.29% |
| Mar 31, 2021 | -45.09% |
| Dec 31, 2020 | 185,596.34% |
| Sep 30, 2020 | -38.82% |